Orbimed Advisors LLC Nurix Therapeutics, Inc. Transaction History

Orbimed Advisors LLC

  • $4.24 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022
SELL
$12.94 - $29.65 $2.39 Million - $5.47 Million
-184,468 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$26.43 - $34.5 $10.4 Million - $13.6 Million
-394,115 Reduced 68.12%
184,468 $5.34 Million
Q3 2021

Nov 15, 2021
BUY
$22.71 - $36.69 $6.33 Million - $10.2 Million
278,583 Added 92.86%
578,583 $17.3 Million
Q3 2020

Nov 16, 2020
BUY
$16.05 - $34.91 $4.82 Million - $10.5 Million
300,000 New
300,000 $10.5 Million

Others Institutions Holding NRIX

# of Institutions
181
Shares Held
68.1M
Call Options Held
78K
Put Options Held
53.8K
View Full List

About Nurix Therapeutics, Inc.

NRIX Quotes by TradingView
  • Ticker NRIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,147,800
  • Market Cap $945M
  • Description
  • Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies...
More about NRIX
Track This Portfolio

Track Orbimed Advisors LLC Portfolio

Follow Orbimed Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Orbimed Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Orbimed Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email